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Abstract
Background: The mechanisms regulating the function and regression of the corpus luteum (CL) have not yet been
elucidated in detail. The regressed CL of cows was previously reported to be filled with unusual vessels like arteriovenous
anastomosis (AVA); however how these vessels are being established during luteolysis remains unknown.
Methods: The bovine CL at different luteal stages and regressing bovine CL induced by prostaglandin F2α (PGF)
were histologically analyzed using light and electron microscopic levels. The changes in mRNA expression of
genes encoding α-smooth muscle actin (SMA; Acta2) and transforming growth factor β1 (Tgfb1) in luteal tissues
were analyzed by quantitative RT-PCR.
Results: AVA-like vessels appeared in the regressed CL with a diameter less than 1.5 cm in which no functional
luteal cells and macrophages were observed. Epithelioid cells in the AVA-like vessel wall were immunoreactive for
SMA, and the lumen of the vessels were narrow. Immunoreaction for SMA was found in the tunica media of
typical arteries and arterioles, and pericytes around capillary vessel. Cells with elongated cytoplasmic processes
―resident fibroblasts expressing vimentin― distributed in the CL parenchyma without any association with
blood vessels are also immunoreactive for SMA, and accumulated around arteries and arterioles during the late-
luteal stage. In the regressed CL, walls of arteries and arterioles consisted of more than two layers of epithelioid
cells positive for both SMA and desmin, suggesting that they are myofibroblasts transformed from fibroblasts. The
percentage of the area positive for SMA and the mRNA expression of Acta2 were significantly increased in the
regressed CL; however, they did not alter when a luteolytic dose of PGF was injected in vivo and collected within
24 h after the injection. On the other hand, Tgfb1, a known regulator for myofibroblast transformation, was
significantly increased in PGF-induced regressing CL as well as in the CL during the late-luteal stage.
Conclusions: SMA-positive myofibroblasts accumulates around the arteries and arterioles to form AVA-like
vessels during luteolysis in cows. PGF indirectly regulates myofibroblast transformation through enhancing the
expression of TGFβ1. These peculiar AVA-like vessels may be involved in the regulation of blood flow in the
bovine CL during luteolysis.
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Background
The corpus luteum (CL) is formed from an ovulated
dominant follicle in the ovary, and secretes progesterone,
which is essential for the establishment and maintenance
of pregnancy. In mammals, the CL undergoes luteolysis
at the end of luteal phase [1]. There are two phases in
luteolysis: functional and structural luteolysis. Functional
luteolysis is characterized by a decrease in serum proges-
terone concentrations and is followed by structural
luteolysis, in which the volume of the CL decreases due
to apoptotic death of luteal cells. It is generally accepted
that spontaneous luteolysis in cows is initiated by
uterus-derived prostaglandin F2α (PGF) if pregnancy
does not occur [2]. In cows, serum concentration of
progesterone markedly decreases approximately 19 days
after ovulation and this is accompanied by an increase in
plasma PGF metabolites, which represents the produc-
tion of PGF in the uterus [3]. An intramuscular injection
of PGF into cows during the mid-luteal stage ―but not
the early-luteal stage― has been shown to induce luteo-
lysis, resulting in a rapid decrease in serum progesterone
levels eight hours after the injection [3, 4]. Although
PGF is a major luteolysin in cows, the molecular mecha-
nisms by which PGF regulates functional and structural
luteolysis currently remain unclear; however, its effects
are known to be mediated by various intra-ovarian fac-
tors, such as endothelin 1, nitric oxide, angiotensin II,
and interferon γ [5–11].
In cows, ovarian blood flow decreases during luteal
regression [4, 12] and the resulting hypoxic condition
affects functional and structural luteolysis [13] although
a temporal increase in blood flow has been reported in
spontaneous and PGF-induced luteolysis [3]. Previous
studies noted morphological changes in the vasculature
during luteolysis in ewes [14] and cows [15]. Sawyer et
al. [14] found that vascular occlusion occurred following
the sloughing of endothelial cells into the lumina of
small blood vessels during luteolysis, suggesting that vas-
cular occlusion causes a decreased blood supply, result-
ing in hypoxic conditions in the CL. Hojo et al. [15]
demonstrated that capillaries disappeared within the CL
at the late and regressed luteal stages, whereas larger
blood vessels that stained for α-smooth muscle actin
(SMA) increased in number. Changes in the vascular
structure have been suggested to contribute to a
decrease in blood flow and luteolytic process in the CL.
Although remodeling of the vasculature in the CL
appears to be essential in the regulation of luteal func-
tion during luteolysis, the mechanisms responsible for
controlling changes in vascular structures in the bovine
CL during luteolysis have yet to be clarified. Höflinger
[16] noted the existence of arteriovenous anastomosis
(AVA)-like vessels in the regressed CL of cows. AVA is
characterized by precapillary connections between small
arteries and veins. AVA called Hoyer-Grosser’s organs
are distributed in the subcutaneous tissue of the tips of
the fingers and toes of humans, and have also been re-
ported in the ears of some animals including rabbits.
The corpora cavernosa penis of various animals pos-
sesses a similar structure in the helicine arteries [17–19].
AVA is a vascular shunt and is involved in the regulation
of blood flow in the skin or corpora cavernosa penis.
Without stimulations by vasodilative molecules such as
nitric oxide secreted from peripheral nerves, AVA con-
tracts and blood flow is remarkably obstructed. AVA
shows a characteristic morphology that is markedly
different from those of normal arteries and veins: unique
round epithelioid cells form the walls of AVA. Epitheli-
oid cells are contractive cells containing SMA in the
cytoplasm, and react to both vasoconstrictive and vaso-
dilative signals such as endothelin and nitric oxide [20].
Because the blood flow is known to decrease during
luteolysis and the appearance of AVA-like vessels is
likely to contribute to a decrease in blood flow in the CL
of cows during luteolysis; however, the role of AVA-like
vessels in regulating the function of CL and how this
structure is constructed in the CL remain unclear.
The objective of this study is to clarify the contribu-
tion of AVA-like vessels to the regulation of luteal
function in cows, we herein investigated how they are




Ovaries with the CL of Holstein cows were obtained at a
local abattoir, kept in normal saline at 25 − 30 °C, and
delivered to the laboratory within 6 h of being collected.
Luteal stages were classified as early-luteal (days 2–3
after ovulation), mid-luteal (days 8–12), late-luteal (days
15–17), and regressed (over day 19) by macroscopic
observations of the CL according to a previous study
[21]. The stages of the bovine CL were classified into
the early-luteal (n = 7), mid-luteal (n = 13), late-luteal
(n = 14), and the regressed stages (n = 31). Collection
of the CL tissues was approved by the local ethical com-
mittee of Hokkaido University (Approval no. 13–0052).
The animal procedures used to collect PGF-induced
regressing CL tissues were approved by the local Institu-
tional Animal Care and Use Committee of the Polish
Academy of Science in Olszyn, Poland (Agreement No.
5/2007, 6/2007 and 88/2007). Healthy, normally cycling
Polish Holstein black and white cows were used for the
collection of PGF-induced regressing CLs. Estrus was
synchronized in cows by two injections of an analogue
PGF (25 mg; Dinoprost, Dinolytic; Pharmacia and
Upjohn, Puurs, Belgium) with an 11-day interval accord-
ing to the manufacturer’s instructions. Ovaries were
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collected 0, 2, 12, and 24 h after the injection of a
luteolytic dose of the PGF analogue (25 mg) on post-
ovulation day 10 using a Hauptner’s effeninator
(Hauptner & Herberholz, Solingen, Germany). Total
25 PGF-treated CL and control mid-luteal CL were
used in this study, and detailed information of the
tissues is summarized in Table 1.
CL tissues dissected out from the ovaries were halved,
and either immersed in fixatives as described below for
the histological analysis or frozen in liquid nitrogen for
RNA purification. Information on the CL used for this
study was summarized in Table 1.
Histological analysis
CL tissues were dissected from the ovaries and
immersed in 4 % paraformaldehyde for 24 h at 4 °C. Tis-
sues were dehydrated through graded series of ethanol
and immersed into xylene, then embedded in paraffin
according to the standard methodology, and 5-μm-thick
sections were obtained. Sections were de-waxed, sub-
jected to Hematoxylin and Eosin staining, and observed
under a light microscope (BX51; Olympus corporation,
Tokyo, Japan). The middle CL parenchyma tissues were
dissected into small pieces and fixed with 2.5 % glutaral-
dehyde for ultrastructural observations under a trans-
mission electron microscope (TEM, H-7100; Hitachi,
Tokyo, Japan). Tissue pieces were post-fixed with 1 %
OsO4 for 1.5 h, dehydrated through a graded series of
ethanol, and embedded into Epon resin (Quetol 812).
Ultra-thin sections were obtained, stained with uranyl
acetate lead citrate, and observed under a TEM.
Immunohistochemistry
All procedures were performed at room temperature.
After deparaffinization, endogenous peroxidase was
blocked by 3 % H2O2 in distilled water for 20 min.
Sections were then incubated with Avidin/Biotin block-
ing solution (Vector Laboratories Inc., Burlingame, CA,
USA) for 15 min each. After washing with phosphate-
buffered saline (PBS) twice, sections were pre-incubated
for non-immune blocking with Block Ace (DS Pharma
Biomedical Co., Ltd., Osaka, Japan) for 60 min. Sections
were then incubated with a mouse anti-SMA antibody
(1:1,000; clone 1A4, #A2574; Sigma-Aldrich Corpor-
ation, St. Louis, MO, USA) in PBS overnight. The
sections were incubated with biotinylated anti-mouse
IgG (1:500; Vector Laboratories Inc.) for 1 h, followed
by an incubation using a Vectastain ABC Elite kit (Vector
Laboratories Inc.) for 1 h. The reaction site of the primary
antibody was visualized using an ImmPACT™ DAB Perox-
idase Substrate Kit (Vector Laboratories Inc.) for 3 min.
Sections were counterstained with hematoxylin and ob-
served under a light microscope. The total CL area in the
section and the SMA-immunoreactive area in the CL were
measured using Image J (http://imagej.nih.gov/ij/), and the
percentage of SMA-positive area per the total CL area was
calculated. Control sections were incubated with PBS
instead of the primary antibody and the disappearance of
the signals was confirmed.
For luteal steroidogenic cell, macrophage, and prolifer-
ating cell staining, antigen retrieval was performed for
1 min in boiling 0.01 M citrate buffer (pH 6.0) using a
pressure cooker. Endogenous peroxidase and Avidin/
Biotin blocking were then performed as described above.
After a pre-incubation with Block Ace for 1 h, the sections
were incubated with either goat anti-3β-hydroxysteroid
dehydrogenase (3β-HSD) (1:2,000; #sc-30820; Santa
Cruz Biotechnology, Inc., Dallas, TX, USA), mouse
anti-MAC387 (1:1,000; #ab22506; Abcam Japan Ltd.,
Tokyo, Japan), which recognizes the L1 or Calprotectin
molecule, an intracytoplasmic antigen expressed by tissue
macrophages, or rabbit anti-Ki-67 antibody (1:200;
Table 1 Information on the bovine corpus luteum used for the present study
A: Normal cycling CL
Luteal stages
EL ML LL Reg
Number of samples For the histological analysis 7 13 14 31
For the qPCR analysis 4 4 5 7
Days after ovulation 2–3 8–12 15–17 >19
Color Flesh, Bloody Orange Yellow Ocher, Brown, White
Size (cm) 1.9 ± 0.19 2.5 ± 0.07 2.1 ± 0.14 0.9 ± 0.06
B: PGF-induced regressing CL
Hours after the PGF injection
0 2 12 24
Number of samples For the histological analysis 4 10 6 3
For the qPCR analysis 5 6 6 4
EL early-luteal, ML mid-luteal, LL late-luteal, Reg regressed
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ThermoFisher Scientific Inc., Waltham, MA, USA) over-
night. Sections incubated with the 3β-HSD antibody were
then incubated with a peroxidase-labeled anti-goat IgG
(1:200; Vector Laboratories Inc.) for 1 h. On the other
hand, MAC387- and Ki-67-stained sections were incu-
bated with biotinylated anti-mouse or rabbit IgG for 1 h
and Vecterstain ABC Elite kit as described above. Reaction
sites for all three antibodies were visualized using an
ImmPACT™ DAB Peroxidase Substrate Kit (Vector La-
boratories Inc.) for 3 min and observed under a light
microscope as described above. The total CL area in the
section and the number of 3β-HSD- or MAC387- immu-
noreactive cells in the CL was measured using Image J,
and the positive cell number in 1 mm2 was calculated.
For double immunostaining for SMA and Ki-67, the
deparafinized sections were rinsed in distilled water and
antigen retrieval was performed by boiling the sections
in 0.01 M citrate buffer (pH 6.0) for 1 min using a pres-
sure cocker. The sections were incubated with Block
Ace for 1 h and rabbit anti-Ki-67 antibody overnight as
described above. After washing with PBS three times,
the sections were incubated with Alexa Fluor 488-
conjugated anti-rabbit IgG (1:200; Life Technologies
Japan, Tokyo, Japan) for 2 h. The sections were again in-
cubated with Block Ace for 1 h and then incubated with
mouse anti-SMA antibody as described above. The bind-
ing site for SMA antibody was visualized using AlexaFluor
594-labeled anti-mouse IgG (1:200; Life Technologies
Japan) and observed under a confocal laser microscope
(FV300; Olympus, Tokyo, Japan).
For triple staining, sections were incubated with a
mouse anti-vimentin antibody (1:500; Dako Japan ltd.,
Tokyo, Japan) overnight, and then with biotinylated
anti-mouse IgG for 1 h as described above. The
antibody-binding site for the 1st primary antibody
against vimentin visualized using the TSA™ Fluores-
cein System (PerkinElmer Inc., Waltham, MA, USA).
The 1st primary antibody was washed out in boiling
0.01 M citrate buffer (pH 6.0) using a microwave for
2.5 min, and sections were then blocked with Block
Ace for 1 h. They were incubated with the 2nd pri-
mary antibody, a rabbit anti-desmin antibody (1:500;
ThermoFisher Scientific Inc.) overnight and with a
Cy5-labeled anti-rabbit antibody (1:200; Jackson
ImmunoResearch Laboratories, Inc., West Grove, PA,
USA) for 2 h. Sections were again blocked with
Block Ace for 60 min and then incubated with a 3rd
primary antibody, the mouse anti-SMA antibody (1:500).
The binding site for the 3rd primary antibody was visual-
ized by AlexaFluor 594-labeled anti-mouse IgG (1:200;
Life Technologies Japan). Sections were observed under a
confocal laser microscope as described above. Lasers used
in this study were Ar (488 nm), HeNe (G) (543 nm), and
HeNe (R) (633 nm).
Quantitative PCR (qPCR)
Total RNA from bovine CL tissues during the early-
luteal (n = 4), mid-luteal (n = 4), late-luteal (n = 5), and
regressed stages (n = 7) was purified using Trizol®
(Thermo Fisher Scientific) according to the manufac-
turer’s instructions. Two hundred nanograms of total
RNA were used to prepare cDNA using a QuantiTect
Reverse Transcription kit (Qiagen Japan Co. Ltd., Tokyo,
Japan). QPCR was performed using a KAPA SYBR First
qPCR kit (Nippon Genetics Co., Ltd., Tokyo Japan)
according to the manufacturer’s instructions. The
sequences of the primer sets used for this study are
listed in Table 2. Primers were pre-validated by standard
PCR and by generating standard curves using qPCR.
The qPCR cycling program consisted of a denaturing
step (95 °C for 3 min), annealing and extension step
(95 °C for 3 s and 60 °C for 20 s repeated for 40 cycles),
and a dissociation step (ramp from 60 to 95 °C) using
Corbett Rotor-gene 6000 (Qiagen Japan Co, Ltd.). The
relative expression levels of each target to the house-
keeping gene (glyceraldehyde 3-phosphate dehydrogen-
ase: Gapdh) were quantified using the ΔCt method.
Statistical analysis
After testing for normality, all statistical analyses were
performed using one-way ANOVA with Tukey’s mul-
tiple comparisons test using GraphPad Prism 6 soft-
ware (GraphPad Software Inc., San Diego, CA, USA),
and P < 0.05 was regarded as significant. Values in the
graphs represent the mean ± SEM.
Results
Characteristic AVA-like vessels appear in the regressed CL
of cows
Figure 1 shows macroscopic images of the equatorial
plane of the bovine CL at each stage. The CL at the
early-luteal stage displayed a flesh or bloody color and
was very soft (Fig. 1a). The CL during the mid-luteal and
late-luteal stages was large with a diameter of more than
Table 2 Primers used for the present study
Gene name Accession no. Forward Reverse Product size
Gapdh BC102589 caccctcaagattgtcagca ggtcataagtccctccacga 103
Acta2 NM_001034502 gccgagatctcaccgactac gtgatcacctgcccatcag 202
Tgfb1 NM_001166068 ccttcctgctcctcatgg ggttgtgctggttgtacagg 276
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2.0 cm (Fig. 1b, c). The color of the CL at the mid-luteal
stage was flesh or orange while that at the late-luteal
stage was yellow (Fig. 1b, c). The regressed CL with a
diameter less than 1.5 cm showed various colors, such
as ocher, brown, or white (Fig. 1d–f ). The color of the
regressed CL occasionally resembled that of the CL at
the early-luteal phase, while the regressed CL was harder
and possessed septa of connective tissue in the CL p-
arenchyma (arrows in Fig. 1e, f ).
Under a light microscope, the parenchyma of the
regressed CL was filled with characteristic vessels posses-
sing thick walls (Fig. 2a). Large arteries with an external
diameter of more than 200 μm possessed a thick tunica
media and were located at the periphery of the CL (arrows
in Fig. 2a). The CL parenchyma contained numerous and
condensed arteries of various sizes (Fig. 2a, b). Vessels with
a diameter of 100–200 μm, possibly modified small arter-
ies, possessed more than four layers of SMA-positive epi-
thelioid cells in their walls and a narrow lumen, possessing
the features of typical AVA (asterisks in Fig. 2a, b). Obser-
vations of AVA-like vessels under an electron microscope
clearly showed the characteristic structure of the vessels
with a similar morphology to that of AVA, particularly in
the small arteries (Fig. 2c). The walls of AVA-like vessels in
the regressed CL consisted of round epithelioid cells, each
of which possessed a basement membrane similar to
smooth muscle cells (asterisks in Fig. 2c). The lumens of
the meandering small-sized vessels were narrow, suggest-
ing their contractive condition (Fig. 2d, e).
SMA-positive cells increase in number during luteolysis
When the regressed bovine CL sections were immuno-
stained for α-smooth muscle actin (SMA), the wall of
the vessels in the CL parenchyma were all immunola-
beled. Thick tunica media of the large vessels at the per-
iphery of the CL was immunoreactive for SMA, whereas
the enlarged tunica intima of the larger arteries was not
(arrow in Fig. 3a). The wall of AVA-like modified arteries
was strongly immunoreactive for SMA (asterisks in
Fig. 3a, b). Small-sized vessels, possibly derived from
arterioles and capillaries, occupied the CL parenchyma
and displayed a spiral running pattern and intense
immunoreactivity for SMA in their walls (Fig. 3a, b).
Because the wall of AVA-like vessels was immuno-
stained with SMA, we next investigated how AVA-like
vessels formed during luteal regression by SMA immu-
nohistochemistry. Tissue sections of the bovine CL
throughout the luteal phases were immunostained for
SMA and observed with special reference to changes in
the vascular structure. During the early- and mid-luteal
stages, SMA-immunoreactive arteries and arterioles of
various sizes were dispersed in the CL; typical arteries
were located in the connective tissues surrounding the
CL and septa within the CL (asterisks in Fig. 3c), and
arterioles were observed throughout the CL parenchyma
(arrows in Fig. 3c, d). Immunoreactivity for SMA was
largely restricted to the tunica media of the arteries
(asterisks in Fig. 3c) and arterioles (arrows in Fig. 3c, d)
as well as cytoplasm of pericytes surrounding capillary
Fig. 1 Macroanatomical images of the bovine CL. The CL was cut through an equatorial plane. The color of the CL during the early-luteal (EL)
stage is bloody or flesh and size was less than 2.0 cm (a). The CL during the mid-luteal (ML) and late-luteal (LL) stages increased in size to more
than 2.0 cm in diameter (b, c). The color of the CL during the ML stage is flesh or orange (b), while that during the LL stage turns to yellow (c).
Regressed CLs are small with a diameter of less than 1.5 cm and show various colors such as ocher (d), brown (e), or white (f). Arrows in E and F
show connective tissue in the CL parenchyma
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vessels (asterisks in Fig. 3d). Other cells extending thin-
cytoplasmic processes between luteal steroidogenic cells
but not being associated with blood vessels occasionally
showed weak immunoreactivity for SMA (arrowhead in
Fig. 3d). During the late-luteal phase, the intensity of the
SMA immunoreaction increased in these stellate cells
(Fig. 3e, f, h). Furthermore, abundant SMA-positive cells
appeared to accumulate around the arteries and arteri-
oles (asterisks in Fig. 3e, f ). Pericytes were strongly
immunoreactive for SMA and the network of the capil-
lary vessels were visible in the CL at the late-luteal stage
(asterisks in Fig. 3f, g). The percentage of the SMA-
positive area (P < 0.0001, Fig. 4a) was significantly
increased in the regressed CL in accordance with the
elevated mRNA expression of Acta2 (P < 0.01, Fig. 4b).
In order to elucidate the relationship between the
appearance of AVA-like vessels and luteal function, we
immunostained the sections with markers for a key en-
zyme in progesterone production (3β-HSD) or macro-
phages (MAC387), which increase in number during
luteolysis [22]. Luteal steroidogenic cells during the mid-
luteal stage expressed 3β-HSD in the cytoplasm (Fig. 5a),
while MAC387-positive macrophages were sparse (Fig. 5b).
During the late-luteal phase, the number of MAC387-
positive macrophages increased, whereas intact steroido-
genic cells with the 3β-HSD immunoreaction was
decreased (Fig. 5c, d). On the other hand, the number of
3β-HSD-positive intact luteal steroidogenic cells and
MAC387-positive macrophages were both negligible in
the regressed CL filled with SMA-positive AVA-like
vessels (Fig. 5e, f ). The number of 3β-HSD-positive ste-
roidogenic cells was significantly low in the regressed CL
(P ≤ 0.0001; Fig. 5g), whereas MAC387-positive macro-
phages increased in number in the CL at the late-luteal
stage (P ≤ 0.05; Fig. 5h). These results indicate that αSMA-
positive AVA-like vessels appear after the structural
luteolysis.
SMA-positive cells are myofibroblasts originating
intraluteal fibroblast
In order to investigate whether an increase in the num-
ber of SMA-positive stellate cells during luteolysis is due
Fig. 2 Histological features of AVA-like vessels in the regressed CL of cows. The regressed CL of cows is filled with AVA-like vessels. Large vessels
with an external diameter of more than 200 μm are found in the periphery of the CL (arrows in a) and vessels of various sizes are distributed
throughout the CL parenchyma (a). Vessels with a diameter of 100–200 μm resemble typical AVA possessing several layer of epithelioid cells in
the walls and narrow lumens (asterisks in a, b). Ultrastructural observations under a TEM show how the epithelioid shape of cells in wall of an
AVA-like vessel, each possessing a basement membrane similar to smooth muscle cells (asterisks in c). The lumen of small-sized vessels is narrow,
showing its contractive condition (d, e). e: endothelial cells
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to cell proliferation or differentiation, sections of the bo-
vine CL were immunostained with SMA and the prolif-
eration marker, Ki-67. Ki-67-positive proliferative cells
were abundant in the CL at the early-luteal stage (Fig. 6a)
but decreased in number at the mid-luteal and late-
luteal stages (Fig. 6b, c). Ki-67-positive cells scattered in
Fig. 3 Representative staining of SMA in the CL during luteal stages. The walls of all vessels in the regressed (Reg) CL exhibited strong
immunoreactivity for SMA (a, b). Tunica media of the large vessels at the periphery of the CL contains SMA immunoreactivity (arrows in a). Cells in the
wall of typical AVA-like vessels with a diameter of 100–200 μm are immunolabeled with SMA (asterisks in a, b). In the CL during the mid-luteal (ML) stages,
the immunoreactivity for SMA is largely restricted to the tunica media of arteries and arterioles (asterisks in c and arrows in c, d). Pericytes surrounding
capillary vessels also immunoreactive for SMA (asterisk in d). Weak immunoreactivity for SMA is found in fibroblast-like cells lying between steroidogenic
luteal cells but not being associated with blood vessels (arrowheads in d). During the late-luteal (LL) stage, abundant SMA-positive fibroblast-like cells
are observed in the CL parenchyma and accumulate around the arteries (asterisks in e). Smooth muscle cells in the arteries (asterisks in e) and arterioles
(arrows in e, f) as well as pericytes (asterisks in f) are immunolabeled with SMA. Capillary vessel network is more visible in the CL at the LL stage (asterisks
in g). Fibroblastic cells with elongated cytoplasmic processes also contain SMA immunoreaction (arrowheads in f, h). Inserts in (d and f) show traverse
images of capillary vessels. Dotted lines in (d and f) display changing points from arterioles to capillary vessels. Cont: negative control image
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the CL parenchyma and were not associated with SMA-
immunoreactivity at the late-luteal stage (Fig. 6d–f ).
Most of Ki-67-positive proliferating cells seem to be lu-
teal steroidogenic cells, endothelial cells, and immune
cells as reported previously [23–26]. Thus, we concluded
that resident cells ―possibly fibroblasts― express SMA
during luteal regression. Triple staining for SMA,
vimentin, and desmin at the late-luteal and regressing
stages showed that certain numbers of SMA-positive
cells distributed throughout the CL parenchyma were
immunoreactive for vimentin, suggesting that they were
resident fibroblasts (Fig. 7a-d). On the other hand, the
small arteries in the intraluteal connective tissues and
arterioles in the CL parenchyma were also immunola-
beled with all three markers (asterisks and arrows in
Fig. 7a-d). Immunoreactivity for desmin was restricted
to the tunica media, whereas that for SMA and vimentin
was detected in the desmin-positive tunica media and in
cells loosely surrounding the arteries (asterisks in 7E–
H). During the early regressing stage, in which luteal ste-
roidogenic cells remained between the crooked vessels,
SMA and desmin co-localized in the walls of the arteries
and arterioles consisting of epithelioid cells (asterisks
and arrows in Fig. 7i–l), while the vimentin immunore-
action was found in the walls of arteries, but was slightly
more abundant outside vessels (Fig. 7j). In the fully
regressed CL, the arterial wall became thicker and
strongly expressed SMA and desmin, whereas immuno-
reactivity for vimentin was restricted more to the out-
side of these vessels (Fig. 7m–p). These results suggest
that a certain population of vimentin-positive fibroblasts
contain SMA, and transform into myofibroblasts that
strongly express desmin during luteal regression, and
accumulate around arteries to form AVA-like vessels.
PGF-induced TGFβ1 may contribute to myofibroblast
transformation
Since PGF is a major luteolysin in cows, it may play a role
in the transformation of fibroblasts to myofibroblasts dur-
ing luteolysis and in the construction of AVA-like vessels.
Therefore, we examined change in the number of SMA-
positive cells and expression of Acta2 mRNA in the CL
collected 2–24 h after an injection of PGF. The staining
pattern of SMA was similar to that in the CL during the
mid-luteal stage, and the area positive for SMA in the CL
and mRNA expression of Acta2 were not affected by the
injection of PGF (Fig. 8a, b). On the other hand, PGF sig-
nificantly enhanced the expression of transforming growth
factor β1 (Tgfb1), which is known to be essential for the
transformation of myofibroblasts [27] (Fig. 8c). The ex-
pression of Tgfb1 was significantly increased during the
late-luteal phase (P ≤ 0.01), and remained at a high level in
the regressed stage (Fig. 8d), suggesting its contribution to
luteolysis.
Discussion
This study revealed the detailed morphology of AVA-
like vessels appearing in the regressed bovine CL and
how they are constructed during luteolysis. The
regressed CL of cows contained abundant atypical ar-
teries with thick walls of epithelioid cells that were
strongly immunoreactive for SMA. These SMA-positive
cells forming the walls of AVA-like vessels are myofi-
broblasts transformed from resident fibroblasts during
luteolysis: SMA-expressing fibroblastic cells with elon-
gated cytoplasmic processes increased in number
during the late-luteal stage and accumulated around
the arteries to form AVA-like vessels. Luteolytic PGF is
unlikely to be a direct cause of this phenomenon, but
Fig. 4 Change in SMA-positive area and Acta2 mRNA expression in the CL during luteal stages. The percentage of the area immunoreactive for
SMA (a) and the mRNA expression of Acta2 significantly increase in the regressed CL (b). Different letters show significant differences
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indirectly regulate the transformation of fibroblasts into
myofibroblasts by enhancing the expression of TGFβ1,
a potent regulator for myofibroblast transformation.
It is well known that the CL development is associated
with angiogenesis and angiogenic factors such as vascu-
lar endothelial growth factor A and fibroblast growth
Fig. 5 Change in numbers of 3β-HSD-positive steroidogenic cells and macrophage in the CL during luteal stages. Abundant luteal steroidogenic
cells immunoreactive for 3β-HSD while a few number of MAC387-positive macrophages are found in the CL at the mid-luteal (ML) stage (a, b). In
the CL at the late-luteal (LL) stage, 3β-HSD-positive cells scatters but abundant MAC387-positive cells are distributed (c, d). In the regressed (Reg)
CL, both 3β-HSD-positive cells and MAC387-positive cells are negligible (e, f). The number of intact 3β-HSD-positive luteal steroidogenic cells
significantly decreases in the regressed CL (g) while MAC387-positive macrophages increase in the CL at the LL stage (h)
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factor 2 are involved in this process [28]. Endothelial
cells proliferate in the developing CL and a fine network
of capillary vessels is established in the CL at the mid-
luteal stages accompanied by an increased serum proges-
terone level [28–30]. During luteal regression, apoptosis
of luteal cells as well as endothelial cells occur and the
number of capillary vessels decreases [31, 32], suggesting
a dynamic vascular remodeling is involved in luteolytic
process. We confirmed an existence of apoptotic cells in
some CL at the late-luteal and early regressed stage, and
certain numbers of apoptotic cells were endothelial cells
(data not shown). However, capillaries were more visible
when pericytes were immunostained for SMA in the CL
at the late-luteal stage. We still do not know the role of
SMA-positive pericytes in the regulation of luteolysis.
On the other hand, some researchers noted an ap-
pearance of non-capillary vessels with thickened wall
in the regressing CL of various animals including
cows [15, 23, 33], that show similar morphology to
AVA-like vessels observed in this study.
The appearance of AVA-like vessels in the regressed bo-
vine CL was previously reported by Höfliger [16]; in stages
more than 25 days after ovulation, the CL consisted of
crooked arteries with the characteristics of AVA. Bauer et
al. [33] also noted an increased number of non-capillary
vessels with thickened vessel walls in the bovine CL.
Hirschberg et al. [34] more recently reported the existence
of AVA-like arteries with thickened medial layers showing
SMA immunoreactivity during the later luteal stage in
cows; however, they reported that “the source of this
abundance of vascular smooth muscle-like cells is pres-
ently not clear”. We revealed here that SMA-positive fi-
broblastic cells increased in number in the CL during the
late-luteal stage, and accumulated around the arteries
distributed in the periphery of the CL and intraluteal
connective tissue. It is important to note that a certain
population of SMA-immunoreactive cells was positive for
vimentin in the CL during the late-luteal stage and prolif-
eration marker, Ki-67, was not associated with an increase
of SMA immunoreaction, suggesting that they are resident
fibroblasts lying between luteal steroidogenic cells. As
luteolysis progressed, the immunoreaction for SMA was
restricted to the vascular epithelioid cells with a strong
immunoreaction for desmin, a smooth muscle cell-
specific intermediate filament. The arterial walls at this
stage became thicker and the lumen became narrower, in-
dicating a contractive condition. It is reasonable to assume
that the origin of SMA-positive epithelioid cells in AVA-
like vessels is myofibroblasts transformed from resident fi-
broblasts in the CL parenchyma. The AVA-like vessels
appearing in association with luteolysis may assist luteoly-
sis by decreasing luteal blood flow in cows.
Fig. 6 Dual immunostaining for SMA and a proliferation marker, Ki-67. Ki-67-positive proliferating cells are abundant in the CL at the early-luteal
(EL) stage (a) but decreases during the mid-luteal (ML) and late-luteal (LL) stages (b, c). Most of SMA-positive cells (red) are not immunoreactive
for Ki-67 (green) (d−f). Bars = 100 μm
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Ovarian blood flow is known to decrease during luteoly-
sis [4, 12]. Miyamoto et al. [3] clearly demonstrated this
change in blood flow during spontaneous and PGF-
induced luteolysis in cows. According to their findings, the
concentrations of plasma PGF metabolites, indicating the
production of uterine PGF, significantly increased 17 days
after ovulation, and luteal blood flow concomitantly
increased. They also showed that an intramuscular injec-
tion of PGF significantly decreased luteal blood flow after
8 h, although a temporal increase of luteal blood flow was
observed after 1 h. In the spontaneously regressing CL, lu-
teal blood flow decreases two days after a peak in plasma
PGF metabolite concentrations [3]. The accumulation of
SMA-positive myofibroblasts around the arteries in the
Fig. 7 Triple immunohistochemical images for SMA, vimentin, and desmin in the bovine CL. In the CL during the late-luteal (LL) stage, the tunica
media of arteries and arterioles of various sizes are immunoreactive for all three markers (asterisks and arrows in a–d). A specific number of
SMA-positive cells distributed in the CL parenchyma contain vimentin (inserts in a–d), suggesting that they are resident fibroblasts. The tunica media
of the artery contains desmin, a smooth muscle-specific intermediate filament, while immunoreactivities for SMA and vimentin are localized in the
tunica media and cells loosely surrounding it (asterisks in e–h). In the early regressing CL, the walls of the arteries (asterisks in i– l) and
crooked arterioles (arrows in i–l) abundantly contain both SMA and desmin, whereas the vimentin immunoreaction is strong outside the vessels (i–l).
In the fully regressed CL, the thick walls of arteries (asterisks in m–p) and crooked vessels consist of SMA and desmin double-positive epithelioid cells.
e–h is a closer view of the areas enclosed by squares in (a–d)
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CL during the late-luteal stage and following the establish-
ment of AVA-like vessels in the regressed CL may be in-
volved in decreasing blood flow during spontaneous
luteolysis in cows. However, we failed to detect AVA-like
vessels in the present PGF-induced regressing CL collected
2–24 h later. We consider that the AVA-like vessels are
gradually established in the CL over the repeated estrous
cycle because the CL with AVA-like vessels we classified
into regressed CL contain the old regressed CL formed
more than two cycle before and remained in the ovary.
The formation of AVA-like vessels may be observed in the
PGF-induced regressing CL collected more than 48 h after
a PGF injection.
PGF is a major luteolysin in cows, but does not appear
to directly regulate the transformation of fibroblasts to
myofibroblasts because the present study failed to show
the accumulation of SMA-positive cells or the up-
regulation of Acta2 mRNA expression with PGF-induced
luteolysis. TGFβ1 is known to affect the transformation of
fibroblasts into myofibroblasts. The results of the present
study revealed that the administration of a luteolytic dose
of PGF significantly enhanced the expression of Tgfb1 in
the bovine CL. This is consistent with a previous study
showing that PGF up-regulated the expression of TGFβ1
[35]. TGFβ1 has been suggested to activate fibroblasts in
order to enhance the expression of contractile proteins
such as SMA, vimentin, and desmin. Maroni and Davis
[36] demonstrated that the treatment of luteal fibroblasts
with TGFβ1 induced the expression of laminin, colla-
gen type 1, and matrix metalloproteinase 1, suggesting
that TGFβ1 stimulated by PGF is involved in fibrotic
changes in the CL during luteolysis. TGFβ1 may in-
fluence steroidogenic actions in the bovine CL similar
to other TGFβ superfamily members such as activin
A and bone morphogenetic proteins [37–39]. Never-
theless, TGFβ1 appears to contribute to the trans-
formation of myofibroblasts during luteolysis in cows
in order to establish AVA-like vessels.
Fig. 8 Effect of PGF on the expression of SMA and TGFβ1. The percentage of the SMA-positive area remains unchanged in the CL 2–24 h after
the injection of a luteolytic dose of PGF (a). The mRNA expression of Acta2 does not change by the PGF injection (b). On the other hand, the
mRNA expression of Tgfb1 ―a known regulator of myofibroblast transformation― is significantly increased in the CL 12 h after the PGF injection
(c) as well as in the CL during the late-luteal (LL) stage and regressed stage (d). Cont: the CL not treated with PGF. ML: mid-luteal, Reg: regressed
CL. *P < 0.05, **P < 0.01
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Conclusions
In conclusion, SMA-positive myofibroblasts accumulate
around arteries to form AVA-like vessels in the regres-
sing CL of cows. This morphological change in the
vasculature appears to be regulated by PGF-induced
TGFβ1, and may be involved in vascular occlusion and a
reduction in blood flow during luteolysis in cows.
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